Not applicableActive Not RecruitingNCT07298291What this trial is testingOcular Proteomics Testing In Chronic AtrophyWho this might be right forAge-Related (Dry) Macular Degeneration ClinOmicsAI 50
Post-approval studies (Phase 4)Study completedNCT06785090What this trial is testingEffects of Bromfenac on Macular Thickness After Phacoemulsification SurgeryWho this might be right forCataractCystoid Macular Edema After Phacoemulsification Inas Abd 87
Post-approval studies (Phase 4)Study completedNCT06330220What this trial is testingVisual Function Change in Wet Age-related Macular Degeneration Patients With Better Baseline Visual AcuityWho this might be right forAge-Related Macular Degeneration Seoul National University Hospital 12
Not applicableStudy completedNCT01524874What this trial is testingComparative Effectiveness of Vitamin D and Repletion StrategiesWho this might be right forHypovitaminosis DInsulin ResistanceDiabetes Bastyr University 66
Not applicableStudy completedNCT01504074What this trial is testingMorphological and Functional Evaluation of Irvine-Gass SyndromeWho this might be right forIrvine Gass Syndrome Medical University of Vienna 50
Not applicableEnded earlyNCT02875704What this trial is testingOxidative Stress In Stargardt Disease, Age Related Macular Degeneration and Diabetic RetinopathyWho this might be right forStargardt DiseaseDiabetic RetinopathyMacular Degeneration (Age Related) Johns Hopkins University 77
Not applicableStudy completedNCT02829606What this trial is testingHead Mounted Eye Tracking Aide for Loss of Central Vision (HETALCEV)Who this might be right forAge-related Macular Degeneration University of Minnesota 8
Testing effectiveness (Phase 2)Study completedNCT04304755What this trial is testingZoledronic Acid as Adjuvant Therapy in Neovascular Age-related Macular Degeneration (Z-AMD)Who this might be right forNeovascular Age-related Macular Degeneration Oslo University Hospital 40
Testing effectiveness (Phase 2)WithdrawnNCT02511613What this trial is testingEffect of Squalamine Lactate Ophthalmic Solution, 0.2% in Subjects With Neovascular Age-Related Macular DegenerationWho this might be right forAge-Related Macular Degeneration Ohr Pharmaceutical Inc.
Not applicableWithdrawnNCT02699216What this trial is testingBioCurrent Electrical Stimulation for the Treatment of Dry ARMDWho this might be right forDry Macular Degeneration DuBois Vision Clinic
Not applicableStudy completedNCT02264938What this trial is testingDrusen Morphology Changes in Nonexudative Age-related Degeneration After Oral Antioxidants SupplementationWho this might be right forMacular Degeneration Germans Trias i Pujol Hospital 35
Not applicableStudy completedNCT05657158What this trial is testingAnalysis of Imaging Features From Patients Treated With Brolucizumab in the Post-marketing Setting With Reports of Retinal Vasculitis and/or Retinal Vascular OcclusionWho this might be right forIntraocular InflammationRetinal Vascular Occlusion Novartis Pharmaceuticals 198
Not applicableNot Yet RecruitingNCT05507840What this trial is testingPhotobiomodulation for Dry Age Related Macula DegenerationWho this might be right forPhotobiomodulationAge-Related Macular Degeneration Oslo University Hospital 121
Testing effectiveness (Phase 2)Ended earlyNCT00464347What this trial is testingTAC-PF, Avastin® in Combination With Photodynamic Therapy to Treat Age Related Macular DegenerationWho this might be right forAge-Related Macular Degeneration National Eye Institute (NEI) 100
Early research (Phase 1)Study completedNCT00659555What this trial is testingStudy Of The Repeat Dosing Of Ketoconazole On The Pharmacokinetics Of A Single Dose Of Pazopanib (GW786034) Eye DropsWho this might be right forMacular Degeneration GlaxoSmithKline 24
Testing effectiveness (Phase 2)Study completedNCT00385333What this trial is testingMetabolic Mapping to Measure Retinal MetabolismWho this might be right forMacular DegenerationDiabetic RetinopathyHippel-Landau Disease+1 more National Eye Institute (NEI) 28
Testing effectiveness (Phase 2)Looking for participantsNCT06659549What this trial is testingEfficacy and Safety Study of GAL-101, 2% Ophthalmic Solution in Non-foveal Geographic Atrophy Secondary to Non-neovascular AMDWho this might be right forGeographic Atrophy of the Macula Galimedix Therapeutics Inc 110
Testing effectiveness (Phase 2)Study completedNCT01247220What this trial is testingREtinal Vein OccLUsion Treatment With Scatter Laser Guided by UWFA in combiNAtion With Ranibizumab StudyWho this might be right forMacular EdemaBranch Retinal Vein Occlusion Retina Associates of Florida, P.A. 12
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07705568What this trial is testingAn Open-label Safety, Tolerability and Exploratory Efficacy Clinical Trial of PST-611 in Geographic AtrophyWho this might be right forGeographic AtrophyAge - Related Macular Degeneration (AMD) Eyevensys 24
Testing effectiveness (Phase 2)UnknownNCT02067013What this trial is testingAnalysis of Aqueous and Vitreous HumorWho this might be right forProliferative Diabetic RetinopathyMacular DegenerationMacular Hole+1 more California Retina Consultants 45